search
Summit Therapeutics
Trends
- 1AstraZeneca invests $2bn in cancer drug partnership with Summit Therapeutics●📈 Astrazeneca invests $2bn in cancer drug tie-up Astrazeneca has invested $2bn in US pharmaceutical firm Summit Therapeu
AstraZeneca has invested $2bn in US biotech firm Summit Therapeutics as part of a major cancer research collaboration. The FTSE 100 drugmaker agreed to buy 109,000 shares in the Nasdaq-listed company at $18.36 per share, funding a tie-up aimed at developing new cancer treatments.
- 2US Stock Futures Fall on Rising Bond Yields, AI Concerns●Dow, S&P 500, Nasdaq Futures Fall Amid Rising Bond Yields, AI Concerns: KOD, SMMT, CLF, VKTX Stocks In Focus
Futures for the Dow, S&P 500 and Nasdaq pointed lower as rising bond yields weighed on markets and investors grew uneasy about valuations tied to artificial intelligence. Single stocks Kodak, Summit Therapeutics, Cleveland-Cliffs and Viking Therapeutics were also flagged as ones to watch in the session ahead. Traders are watching whether yields keep climbing and how AI-exposed names hold up.